Abstract
INTRODUCTION White matter hyperintensities (WMH), a major cerebral small vessel disease marker, may arise from different pathologies depending on their location. We explored clinical and genetic correlates of agnostically derived spatial WMH patterns in two longitudinal population-based cohorts (3C-Dijon, LIFE-Adult).
METHODS We derived seven WMH spatial patterns using Bullseye segmentation in 2,736 individuals aged 65+ and explored their associations with vascular and genetic risk factors, cognitive performance, dementia and stroke incidence.
RESULTS WMH in the fronto-parietal and anterior periventricular region were associated with blood pressure traits, WMH genetic risk score (GRS), baseline and decline in general cognitive performance, incident all-cause dementia and ischemic stroke. Juxtacortical-deep occipital WMH were not associated with vascular risk factors and WMH GRS, but with incident all-cause dementia and intracerebral hemorrhage.
CONCLUSION Accounting for WMH spatial distribution is key to decipher mechanisms underlying cerebral small vessel disease subtypes, an essential step towards personalized therapeutic approaches.
Highlights
We studied spatial patterns of white matter hyperintensities in 2736 participants
Blood pressure was associated with fronto-parietal and anterior periventricular WMH
Anterior periventricular WMH predicted dementia and stroke risk
Juxtacortical-deep occipital WMH burden was not associated with blood pressure or WMH genetic risk
Juxtacortical-deep occipital WMH predicted dementia and intracerebral hemorrhage.
Research in context
Systematic Review: We performed a literature search using PubMed and Google Scholar. Most literature focuses on risk factors and outcomes for total WMH volume. Existing approaches to study WMH spatial patterns are heterogenous and often performed in single cohorts only.
Interpretation: Across two independent cohorts of older community-dwelling individuals, we show that WMH in the anterior periventricular and juxtacortical-deep occipital WMH show differential associations with risk factors and clinical outcomes. Anterior periventricular WMH were associated with blood pressure (BP) traits, WMH genetic risk, cognitive performance, dementia and incident stroke. Juxtacortical-deep occipital WMH did not relate to BP or WMH genetic risk and were predictive of dementia and intracerebral hemorrhage. These findings are important for characterizing small vessel disease subtypes and developing targeted prevention and therapeutic strategies.
Future Directions: Additional research is warranted to validate these findings and relate them to underlying vascular pathologies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The 3C study (Three-City) is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen-Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The Fondation Plan Alzheimer partly funded the follow-up of the study. The 3C study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l Education Nationale Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, la Caisse Nationale de Solidarite et d Autonomie, and the Ministry of Research-INSERM Programme Cohortes et collections de donnees biologiques. This project is supported by a grant overseen by the French National Research Agency (ANR) as part of the "Investment for the Future" Program (ANR-18-RHUS-0002, [https://rhu-shiva.com/en/ | https://rhu-shiva.com/en/]) and by the Precision and global vascular brain health institute funded by the France 2030 investment plan as part of the IHU3 initiative (ANR-23-IAHU-0001, [https://vbhi-institute.org/ | https://vbhi-institute.org/]). LIFE-Adult was initiated by the LIFE Leipzig Research Center for Civilization Diseases, Leipzig University and funded by the EU, the European Social Fund, the European Regional Development Fund, and Free State Saxonys excellence initiative; project numbers: 713-241202, 14505/2470, 14575/2470). FB was supported by the German Research Foundation (DFG) (Walther-Benjamin program, project number: 464596826). AVW was supported by the DFG (SFB 1052, project number 209933838).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical committee of Kremlin-Bicetre University Hospital gave ethical approval for this work. Ethical committee of the University of Leipzig gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The sections "Funding" and "Data and Code availability" were updated by including information on the Three Cities study.
12 Data and Code availability
Due to potential identifiability of individuals from demographic and medical information, we cannot share the data used in this study openly.
The Three-City study is managed by the UMR1219, Bordeaux Population Health Research Center, Bordeaux University, France. Data coming from the Three-City study can be made freely available to interested researchers upon request: http://www.three-citystudy.com/the-three-city-study.php. Contact email address: E3C.CoordinatingCenter{at}u-bordeaux.fr.
Raw data from the LIFE-Adult cohort can be requested via the LIFE data center (https://ldp.life.uni-leipzig.de/).
All code used for analyses in this manuscript is available on https://gitlab.gwdg.de/frauke.beyer/multivariate_risk_svd.
